Cargando…

Systemically Administered Ligands of Toll-Like Receptor 2, -4, and -9 Induce Distinct Inflammatory Responses in the Murine Lung

Objective. To determine whether systemically administered TLR ligands differentially modulate pulmonary inflammation. Methods. Equipotent doses of LPS (20 mg/kg), CpG-ODN (1668-thioat 1 nmol/g), or LTA (15 mg/kg) were determined via TNF activity assay. C57BL/6 mice were challenged intraperitoneally....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ehrentraut, H., Meyer, R., Schwederski, M., Ehrentraut, S., Velten, M., Grohé, C., Knuefermann, P., Baumgarten, G., Boehm, O.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086362/ https://www.ncbi.nlm.nih.gov/pubmed/21547259 http://dx.doi.org/10.1155/2011/746532

Ejemplares similares

CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo
por: Knuefermann, Pascal, et al.
Publicado: (2007)

TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo
por: Boehm, Olaf, et al.
Publicado: (2013)

Toll-Like Receptor 9 Promotes Cardiac Inflammation and Heart Failure during Polymicrobial Sepsis
por: Lohner, Ralph, et al.
Publicado: (2013)

Vascular Dysfunction following Polymicrobial Sepsis: Role of Pattern Recognition Receptors
por: Ehrentraut, Stefan Felix, et al.
Publicado: (2012)

Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overload
por: Bualeong, Tippaporn, et al.
Publicado: (2016)

Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation
por: Markowski, P., et al.
Publicado: (2013)

Toll-like receptor 4 deficiency: Smaller infarcts, but nogain in function
por: Kim, Se-Chan, et al.
Publicado: (2007)

Tlr4 Deficiency Protects against Cardiac Pressure Overload Induced Hyperinflammation
por: Ehrentraut, Heidi, et al.
Publicado: (2015)

Synthetic CpG oligonucleotides induce a genetic profile ameliorating murine myocardial I/R injury
por: Hilbert, Tobias, et al.
Publicado: (2018)

In Vivo TLR9 Inhibition Attenuates CpG-Induced Myocardial Dysfunction
por: Boehm, O., et al.
Publicado: (2013)

Experimental murine acute lung injury induces increase of pulmonary TIE2-expressing macrophages
por: Ehrentraut, Heidi, et al.
Publicado: (2018)

Actions of Adenosine on Cullin Neddylation: Implications for Inflammatory Responses
por: Curtis, Valerie F., et al.
Publicado: (2014)

Immune Modulatory Effects of Human Chorionic Gonadotropin on Dendritic Cells Supporting Fetal Survival in Murine Pregnancy
por: Dauven, Dominique, et al.
Publicado: (2016)

Determinants of Divergent Adaptive Immune Responses after Airway Sensitization with Ligands of Toll-Like Receptor 5 or Toll-Like Receptor 9
por: Lee, Linda M., et al.
Publicado: (2016)

Inflammatory Role of Toll-Like Receptors in Human and Murine Adipose Tissue
por: Poulain-Godefroy, Odile, et al.
Publicado: (2010)

Toll-Like Receptors, Their Ligands, and Atherosclerosis
por: Hodgkinson, Conrad P., et al.
Publicado: (2011)

Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell Subsets
por: Gururajan, Murali, et al.
Publicado: (2007)

Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis
por: Bode, Christian, et al.
Publicado: (2015)

Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
por: Christensen, Sean R., et al.
Publicado: (2005)

The role of Toll-like receptor 9 in a murine model of Cryptococcus gattii infection
por: da Silva-Junior, Elias Barbosa, et al.
Publicado: (2021)

A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models
por: Adlard, Amy L, et al.
Publicado: (2014)

Technology of gallium nitride crystal growth
por: Ehrentraut, Dirk, et al.
Publicado: (2010)

The Toll-like Receptor 2/6 Ligand MALP-2 Reduces the Viability of Mycobacterium tuberculosis in Murine Macrophages
por: Palma, Carla, et al.
Publicado: (2009)

Poke Weed Mitogen Requires Toll-Like Receptor Ligands for Proliferative Activity in Human and Murine B Lymphocytes
por: Bekeredjian-Ding, Isabelle, et al.
Publicado: (2012)

Toll-like receptor 9 and the inflammatory response to surgical trauma and cardiopulmonary bypass
por: Naase, Hatam, et al.
Publicado: (2020)

Endogenous toll-like receptor ligands and their biological significance
por: Yu, Li, et al.
Publicado: (2010)

Toll-like receptor ligands regulate the migratory pattern of leukocytes
por: Nieto, J C, et al.
Publicado: (2010)

Continuum mechanics and applications in geophysics and the environment
por: Straughan, Brian, et al.
Publicado: (2001)

Bisphenol A Does Not Mimic Estrogen in the Promotion of the In Vitro Response of Murine Dendritic Cells to Toll-Like Receptor Ligands
por: Chakhtoura, Marita, et al.
Publicado: (2017)

Lipoteichoic Acid Induces Unique Inflammatory Responses when Compared to Other Toll-Like Receptor 2 Ligands
por: Long, Elizabeth M., et al.
Publicado: (2009)

Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands
por: Barbalat, Roman, et al.
Publicado: (2009)

S284: HEPATOCYTE TOLL-LIKE RECEPTORS MEDIATE THE HEPCIDIN INFLAMMATORY RESPONSE TO PATHOGENS AND PATHOGEN-DERIVED LIGANDS
por: Bonitz, Katharina, et al.
Publicado: (2023)

Characterization of Chicken Thrombocyte Responses to Toll-Like Receptor Ligands
por: St. Paul, Michael, et al.
Publicado: (2012)

A new “sweet” ligand for Toll-like receptor 4
por: Deierborg, Tomas, et al.
Publicado: (2015)

Activation of Innate Immunity by Bacterial Ligands of Toll-Like Receptors
por: Akhmatova, Nelli K., et al.
Publicado: (2014)

Trial watch: Toll-like receptor ligands in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2023)

Toll-Like Receptor 9 in Breast Cancer
por: Sandholm, Jouko, et al.
Publicado: (2014)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks
por: Ehrentraut, Stefan Felix, et al.
Publicado: (2020)

Plasma Cell Alloantigen 1 and IL-10 Secretion Define Two Distinct Peritoneal B1a B Cell Subsets With Opposite Functions, PC1(high) Cells Being Protective and PC1(low) Cells Harmful for the Growing Fetus
por: Schumacher, Anne, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ljcv09d770otck383lh656js9o